AKR1B10 and nasopharyngeal carcinoma: In the present study, we have found that both AKR1B10 protein and mRNA levels were reduced in most of NPC tumors compared with para-carcinoma and benign tissues, which further suggests that AKR1B10 expression is down-regulated in the digestive tract cancers.